The Clinical Program Lead (CPL) provides strategic medical guidance and leads the development of experimental oncology agents in the TCO portfolio, starting from Portfolio Entry/Drug Candidate (PE/DC) of preclinical development through the Transition Decision Point (TDP). This role requires providing strategic medical and scientific leadership to cross-functional project teams for new oncology agents, including small molecules, biologics, and radioligand therapies. The CPL is responsible for creating clinical development strategies, integrating preclinical data, and collaborating with various departments to optimize development plans. While registration studies are not directly managed, the CPL must establish an early clinical development strategy that supports subsequent registration trials. The role involves leading Biomedical Research Early Program Teams (BPTs) and potentially multiple global project teams, ensuring the safe, ethical, and efficient conduct of trials in compliance with Good Clinical Practice (GCP) and Novartis Standard Operating Procedures. The CPL will also interact with external experts, investigators, and regulatory authorities, and contribute to scientific publications.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree